Free Radicals in Peritoneal Dialysis: Agents of Damage?

Halliwell B. , Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1–14.

Spragg R.G. , Hinshaw D.B. , Hyslop P.A. Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388Dl cells after oxidant injury. J Clin Invest 1985; 76: 1471–6.

Andreoli S.P. , McAteer J.A. Reactive oxygen molecule-mediated injury in endothelial and renal tubular epithelial cells in vitro. Kidney Int 1990; 38: 785–94.

Freeman B.A. , Crapo J.D. Biology of disease. Free radicals and tissue injury. Lab Invest 1982; 47: 412–26.

Farber J.L. , Kyle M.E. , Coleman J.B. Biology of disease. Mechanisms of cell injury by activated oxygen species. Lab Invest 1990; 62: 670–9.

Cross C.E. Oxygen radicals and human disease. Ann Intern Med 1987; 526–45.

Gutteridge J.M.C. , Richmond R. , Halliwell B. Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem J 1979; 184: 469–72.

Tappel A.L. Vitamin E and free radical peroxidation of lipids. Ann NY Acad Sci 1972; 203: 12–28.

Wefers H. , Sies H. The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. Eur J Biochem 1988; 174: 353–7.

Hollstein M.C. , Brooks P. , Linn S. Hydroxymethyluracil DNA glycosylase in mamma lian cells. Proc Natl Acad Sci USA 1984; 81: 4003–7.

Marcillat O. , Zhang Y. , Lin S.W. Mitochondria contain a proteolytic system which can recognize and degrade oxidatively -denaturated proteins. Biochem J 1988; 254: 677–83.

Harman D. Aging: A theory based on free radicals and radiation chemistry. J Gerontol 1956; 11: 298–300.

Troll W. , Wiesner R. The role of oxygen radicals as a possible mechanism of tumor promotion. Ann Rev Pharmacol Toxicol 1985; 25: 509–28.

Becker L.C. , Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 1987; 30: 23–44.

Baker G.L. , Corry R.J. , Autor A.P. Oxygen-free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Ann Surg 1985; 202: 628–41.

Brigham K.L. Role offreeradicals in lung injury. Chest 1986; 89: 859–63.

Shah S.U. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989; 35: 1093–106.

Fantone J.C. , Ward P.A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107: 397418.

Babior B.M. Oxygen-depehdent microbial killing by phagocytes. New Engl J Med 1987; 298: 659–94.

Root R.K. , Metcalf J.A. H2O2 release from human granulocytes during phagocytosis: Relationship to superoxide anion formation and cellular catabolism of H2O2. Studies with normal and cytochalasin B treated cells. J Clin Invest 1977; 60: 1266–79.

Klebanoff S.J. Phagocytic cells: Products of oxygen metabolism. In: Gallin J.I. , Goldstein I.M. , Snyderman R. , eds. Inflammation. Basic principles and clinical correlates. New York: Raven, 1988: 391–444.

Weiss S.J. Tissue destruction by neutrophils. New Engl J Med 1989; 320: 365–76.

Test S.T. , Weiss S.J. The generation and utilization of chlorinated oxidants by human neutrophils. Adv Free Radical Biol Med 1988; 2: 91–116.

Canavese C. , Stratta P. , Vercellone A. Oxygen free radicals in nephrology. Int J Artif Organs 1987; 10: 379–89.

Shainkin-Kestenbaum R. , Giatt Y. , Berlyne G.M. The presence and toxicity of guanidinoproprionic acid in uremia. Kidney Int 1975; 7: 302–5.

Costagliola C. , Romano L. , Scoric P. Anemia and chronic renal failure: The possible role of the oxidative state of glutathione. Nephrol 1989; 52: 11–4.

Gutteridge M.C. , Quinlan G.J. , Clarkletal Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta 1985; 835: 441–7.

Berlyne G.M. , Dudek E. , Adler A.J. Silicon metabolism: The basic facts in renal failure. Kidney Int 1985; 28(Suppl 17): 175–7.

Shainkin-Kestenbaum R. , Caruso C. , Berlyne G.M. Reduced superoxide dismutase activity in erythrocytes of dialysis patients: A possible factor in the etiology of uremic anemia. Nephron 1990; 55: 251–3.

Paul J.L. , Man N.K. , Moat ti N. Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis. Nephrologie 1991; 12: 4–7.

Turi S. , Nemeth I. , Vargha I. Erythrocyte defense mechanisms against free oxygen radicals in hemodialysed uraemic children. Pediatr Nephrol 1991; 5: 179–83.

Kuroda M. , Asaka S. , Tofuku Y. Serum antioxidant activity in uremic patients. Nephron 1985; 41: 293–8.

Rhee M.S. , Kondrick S. , McGoldrick M.D. Enhancement of chemiluminescence in plasma from chronic renal failure patients. Fed Proc 1982; 41: 933.

Rhee M.S. , Goldrick M.D. , Meuwissen H.J. Serum factor from patients with chronic renal failure enhances polymorphonuclear leukocyte oxidative metabolism. Nephron 1986; 42: 6–13.

St Martin S. , Zysow B. , Meuwissen H. Chemiluminescence detection of polymorphonuclear leukocyte stimulating factor in patients with chronic renal failure before and after transplantation. Clin Nephrol 1985; 24: 104–5.

Abrutyn E. , Solomons N.W. , St Clair L. Granulocyte function in patients with chronic renal failure: Surface adherence, phagocytosis and bactericidal activity in vitro. J Infect Dis 1977; 135: 1–8.

Chreitin J.H. , Garagus V.F. Phagocytosis and nitroblue tetrazolium reduction in uremia. Experientia 1973; 29: 612–3.

Eckardt K.U. , Eckardt H. , Harber M.J. Analysis of polymorphonuclear leukocyte respiratory burst activity in uremic patients using whole blood chemiluminescence. Nephron 1986; 43: 274–8.

Sulowicz W. , Komorowska Z. , Hanicki A. The enzymatic activities and NBT reduction test of granulocytes in untreated and dialyzed uremic patients. Acta Haematol (Basel) 1979; 61: 144–9.

Hirabayashi Y. , Kobayashi T. , Nishikawa A. Oxidative metabolism and phagocytosis of polymorphonuclear leukocytes in patients with chronic renal failure. Nephron 1988; 49: 305–12.

Ono K. Effectoflarge dose vitamin E supplementation on anemia in hemodialysis patients. Nephron 1985; 40: 440–5.

Smith M.C. , Dunn M.J. Impaired platelet thromboxane production in renal failure. Nephron 1981; 29: 133–7.

Taccone-Gallucci M. , Lubrano R. , Del Principe D. Platelet lipid peroxidation in hemodialysis patients: Effect of vitamin E supplementation. Nephrol Dial Transplant 1989; 4: 975–8.

Yalcin A.S. , Yurtkuran M. , Dilek K. The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients. Clin Chim Acta 1989; 185: 109–12.

Maher E.R. , Wickens D.G. , Griffin J.F.A. Increased freeradical activity during hemodialysis. Nephrol Dial Transplant 1987; 2: 169–71.

Kuwahara T. , Markert M. , Wauters J.P. Neutrophil oxygen radical production by dialysis membranes. Nephrol Dial Transplant 1988; 3: 661–5.

Trznadel K. , Luciak M. , Pawlicki L. Superoxide anion generation and lipid peroxidation process during hemodialysis with reused cuprophan dialyzers. Free Radical Biol Med 1990; 8: 429–32.

Girelli D. , Lopo A. , Trevisan M.T. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in CAPD patients. Perit Dial Int 1992; 12: 205–10.

Taylor J.E. , Scott N. , Bridges A. Lipid peroxidation and antioxidants in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12: 252–6.

Taccone-Gallucci M. , Giardini O. , Lubrano R. Red blood cell membrane lipid peroxidation in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 1986; 6: 92–5.

Goldstein C.S. , Bomalaski J.S. , Zurier R.B. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis. Kidney Int 1984; 26: 733–40.

Rubin J. , Lin L.M. , Lewis R. Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 1983; 20: 140–4.

Gagnon R.F. , Obst G. , Richards G.K. Effect of drug additives to peritoneal dialysis solutions on the viability and function of mouse peritoneal cells. Nephron 1990; 56: 201–5.

Duwe A.K. , Vas S.I. , Weatherhead J.W. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981; 33: 130–5.

Van Bronswijk H. , Verbrugh H.A. , Heezius ECJM Dialysis fluid and local host resistance in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1988; 7: 368–73.

Ing B.L. , Gupta D.K. , Nawab Z.M. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 1988; 11: 351–4.

Cullom E.T. , Moore H.L. , Nolph K.D. pH equilibration with acetate and lactate solutions during peritoneal dialysis. Perit Dial Bull 1985; 5: 123–6.

Alobaidi H.M. , Coles G.A. , Davies M. Host defence in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1: 16–21.

Topley N. , Alobaidi H.M.M. , Davies M. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.

Roos D. The metabolic response to phagocytosis. In: Weissman G. , ed. The cells biology of inflammation. Amsterdam: Elsevier/North-Holland Biomedical, 1980: 337 -87.

Keane W.F. , Peterson P.K. Host defence mechanisms of the peritoneal cavity and in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1984; 4: 122–7.

Rubin J. , McFarland S. , Hellems E.W. Peritoneal dialysis during peritonitis. Kidney Int 1981; 19: 460–4.

Petrone W.F. , English D. K. , Wong K. Free radicals and inflammation: Superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA 1980; 77: 1159–60.

Zimmerli W. , Seligmann B. , Gallin J.I. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi expression. J Clin lnvest 1986; 77: 925–32.

Paty P.B. , Graeff R.W. , Waldman F.M. Biologic priming of neutrophils in subcutaneous wounds. Arch Surg 1988; 123: 1509–13.

Tsujimoto M. , Yokata S. , Vilcek J. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Comm 1986; 137: 1094–100.

Ferrante A. , Nandoskar M. , Walz A. Effects of tumor necrosis factor alpha and interleukin-l alpha and beta on neutrophil migration, respiratory burst and degranulation. Int Archs Allergy Appl Immunol 1988; 86: 82–91.

Henson P.M. , Johnston R.B. Tissue injury and inflammation. Oxidants, proteinases and cationic proteins. J Clin Invest 1987; 79: 669–74.

Breborowicz A. , Wieczorowska K. , Witowski J. Toxic effect offree radicals to human mesothelial cells and the protective effect of vitamin E. Perit Dial Int 1991; 11(Suppl 1): 35a.

Weiss S.J. , Young J. , Lo Boglio A.F. Roleofhydrogen peroxide in neutrophil mediated destruction of cultured endothelial cells. J Clin Invest 1981; 68: 714–21.

Simon R.H. , Scoggin C.H. , Patterson D. Hydrogenperoxide causes the fatal injury to human fibroblasts exposed to oxygen radicals. J Biol Chem 1981; 256: 7181–6.

Kellog E.W. , Fridovich J. Liposome oxidation and erythrocyte lysis by enzymatically generated superoxide and hydrogen peroxide. J Biol Chem 1977; 252: 6721–8.

Del Maestro R.F. , Thaw H.H. , Bjork J. Free radicals as mediators of tissue injury. Acta Physiol Scand 1980; SuppI492: 43–57.

Halliwell B. , Gutteridge J.M.C. The importance of free radicals and catalytic metal ions in human disease. Mol Aspects Med 1985; 8: 89–193.

Fligie ISEG , Lee E.C. , McCoy J.P. Proteindegradation following treatment with hydrogen peroxide. Am J Pathol 1984; 115: 418–25.

Hay E.D. ed. Cell biology of the extracellular matrix. New York: Plenum, 1981.

Weiss S.J. , Peppin G. , Ortiz G. Oxidative auto activation of latent collagenase by human neutrophils. Science 1985; 227: 747–9.

Weiss S.J. , Peppin G.L. Collagenolytic metalloenzymes of human neutrophils: Characteristics, regulation an d potential function in vivo. Biochem Pharmacol 1986; 35: 3189–97.

Carp H. , Janoff A. Potential mediator of inflammation: Phagocyte-derived oxidants suppress the elastase inhibitory capacity of alpha1–proteinase inhibitor in vitro. J Clin Invest 1980; 66: 987–95.

Janoff A. Elastase in tissue injury. Ann Rev Med 1985; 36: 207–16.

Beelen R.H.J. , Van der Meulen J. , Verbrugh H. CAPD, a permanent state of peritonitis: A study of peroxidase activity. In: Maher J.F. , Winchester J.F. , eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Associates, 1986: 524–30.

Lewis S. , Holmes C. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1991; 9: 14–21.

Bos H.J. , Struijk D.G. , Tuk C.W. Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence. Nephron 1991; 59: 508–9.

Bos H.J. , Meyer F. , Jos C. Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions. Kidney Int 1989; 36: 20–6.

Davies S.J. , Suassuna J. , Ogg C.S. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int 1989; 36: 661–8.

Breborowicz A. , Wieczorowska K. , Knapowski J. Peroxidation of peritoneum during peritoneal dialysis. Perit Dial Int 1991; 11: 32a.